Stand Up To Cancer today announced a new $5 million grant from Bristol Myers Squibb to fund research and education efforts aimed at achieving health equity for underserved lung cancer patients, including Black people and people living in rural communities.
After Joy Leath was diagnosed with breast cancer toward the end of 2019, she knew she was in for the fight of her life.
Stand Up To Cancer’s new initiative aims to increase minority representation in these potentially life-saving trials.
Although clinical trials are often performed throughout different parts of the world, often their demographic makeup—the gender, age and race of participants—has a certain kind of uniformity.
Stand Up To Cancer, a nonprofit that supports funding for cancer research, launched a new initiative to expand minority representation in clinical trials.
Precision medicine holds significant promise for cancer care but may be out of reach for minority populations due to a lack of diversity among participants in clinical trials.
Recognizing the need to improve access to genetic testing for cancer risk, several groups set out to explore the use of…
Screening for breast and ovarian cancer genes might be added to the list of medical tests that can be safely and effectively done from home, new research suggests.
